Fact CheckerSign in

NCT06205225Recruiting

iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure

iCardia4HF: A Multi-component mHealth App and Tailored Text-messaging Intervention to Promote Self-care Adherence and Improve Health Outcomes in Patients With Chronic Heart Failure

Source: ClinicalTrials.gov · Last updated 30 Jan 2026

Brief summary (registry, in English)

The goal of this factorial randomized trial is to examine the independent and synergistic efficacies of two mobile health technology interventions in people with chronic heart failure. The first intervention involves the use of multiple consumer mHealth apps and sensor devices (MyApps) for heart failure self-care (maintenance, monitoring, and management). The second intervention is a program of tailored text messages (Text4HF) targeting modifiable behavioral factors associated with heart failure self-care non-adherence. The main questions this study aims to answer are: 1. Can the use of consumer mHealth apps and devices (MyApps) improve heart failure self-care and reduce days lost due to cardiovascular hospitalization or death for any cause? 2. Can a program of individually tailored text messages (Text4HF) improve heart failure self-care and reduce the days lost due to cardiovascular hospitalization or death for any cause? 3. Can MyApps and Text4HF combined lead to greater improvements in heart failure self-care and days lost due to cardiovascular hospitalization or death for any cause

Status (registry)
Recruiting
Study type
Interventional
Enrollment
360 (estimated)
First submitted
3 Jan 2024
Start date
4 Oct 2024
Primary completion date
31 Mar 2028
Lead sponsor
University of Illinois Chicago
NCT number
NCT06205225

What you commit to

  • Study type: Interventional
  • Planned participants: 360
  • From 4 Oct 2024 to the primary completion date, 31 Mar 2028
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Acute coronary syndrome within the last 7 days before randomization
  • Revascularization and/or CRT implantation within 28 days before randomization
  • Individuals who have a home nurse or are not able to take care of self (eat, dress, walk, bathe, take medications, or use the toilet)

Other illness

  • High urgent listed for heart transplantation
  • Chronic renal insufficiency with hemodialysis or estimated Glomerular Filtration Rate \<25 mL
  • Active cancer, currently undergoing treatment (e.g. radiation immunotherapy)
  • Existence of any disease reducing life expectancy to less than 1 year
  • Cognitive impairment (e.g., Dementia, Parkinson disease, Alzheimer disease, MoCA\<18, impaired self-determination, lacking ability to communicate)
  • Major physical impairment (e.g., inability to walk, bound on a wheelchair)

Other

  • Implanted ventricular assist device
  • Planned revascularization, transcatheter aortic valve implantation, MitraClip and/or CRT implantation within 3 months after randomization
  • End-stage HF (hospice candidate)
  • Discharge to a setting other than home
  • Unwillingness to use study equipment
  • Active substance abuse
  • Currently pregnant, less than 3-month post-partum or pregnancy anticipated during the study
  • Participation in other treatment studies or remote patient management programs
  • Participation in the iCardia4H pilot trial (conducted before this study)

Who the study is looking for

  • Diagnosis of Stage C Heart Failure
  • ≥ 18 years of age
  • Transthoracic Echocardiogram or Cardiac MRI performed in the last 3 years and LVEF results available
  • Patient is actively treated with oral loop diuretics for chronic heart failure
  • Hospitalization due to acute decompensated heart failure within 24 months before randomization and/or insufficient self-care per SCHFI assessment (score of ≤3, in at least two items of the SCHFI v7.2 maintenance, symptom monitoring, or self-care management subscale)
  • Ability to speak and read English

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Illinois Hospital & Health Sciences System
Coordinator of this site? Confirm its status
ChicagoUnited StatesRecruiting
Rush University Medical Center
Coordinator of this site? Confirm its status
ChicagoUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.